Ayşe AŞCI ARSLAN, Firuze ERGİN, Emine Mine Çomak GÖÇER, Ahmet KÜÇÜKÇETİN

Probiyotikler ile İlgili Yasal Düzenlemeler

Birleşmiş Milletler Gıda ve Tarım Örgütü (FAO) ve Dünya Sağlık Örgütü (WHO) tarafından üzerinde uzlaşılan tanıma göre probiyotikler, yeterli miktarda alındığı zaman konakçı üzerinde sağlığa yararlı etkiler sağlayan canlı mikroorganizmalardır. Besleyici değeri ve sağlık ile ilgili olumlu özellikleri nedeniyle son yıllarda probiyotik ürünlerin tüketimine ilgi artmaktadır. Probiyotik ürünlerin insan sağlığına faydaları laktoz toleransını arttırması, sindirim sistemi enfeksiyonlarını ve alerji belirtilerini azaltması, kanseri ve yüksek kolesterol riskini engellemesi ile bağışıklık sistemini kuvvetlendirmesi olarak sıralanabilmektedir. Probiyotik ürünlerin sağlık üzerine olumlu etkileri nedeniyle dünyada önemli bir pazar haline gelmesi üreticilerin sağlıkla ilgili iddiaları ürünlerinde kullanmak istemelerine neden olmuştur. Bu nedenle bazı ülkeler ve kuruluşlar gıda güvenliğini ve tüketiciyi korumak amacıyla kendi yasal sistemlerini geliştirmiştir. Bu derlemede FAO/WHO, Amerika Birleşik Devletleri, Avrupa Birliği, Japonya, Hindistan ve Türkiye gibi farklı ülke ve kuruluşların probiyotik ürünlerle ilgili yasal düzenlemeleri hakkında bilgi verilmesi amaçlanmaktadır

Legislations on Probiotics

Probiotics are defined by the Food and Agriculture Organization of the United Nations (FAO) and World Health Organization (WHO) as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. In recent years, there has been a growing interest in consuming probiotic products mainly due to the nutritional value and healthy aspects associated with these products. The benefits of probiotic products on human health include an increase in lactose tolerance, reduction in digestive system infections and allergy symptoms, prevention of cancer and high cholesterol risk and stimulation of human immune system. Probiotic products have become an important commodity in worldwide markets because of their positive effects on human health, and this has led food producers to use special health claims on products containing probiotics. Therefore, some countries and organizations developed their own legislative systems to ensure food safety and consumer protection. The aim of this study is to give information about legal regulations on probiotics in some countries and organizations like FAO/WHO, the United States of America, the European Union, Japan, India and Turkey.

PDF

___

Bigliardi, B., Galati, F., 2013. Innovation trends in the food industry: The case of functional foods. Trends in Food Science & Technology 31:118-129.
Çomak Göçer, E.M., Aşcı Arslan, A., Ergin F., Küçükçetin A., 2013. Probiyotik bakterilerin mikroenkapsülasyonu. Yetişkin ve Çocuklarda Probiyotikler 1: 33-37.
Dayısoylu, K.S., Gezginç, Y., Cingöz, A., 2014. Fonksiyonel gıda mı, fonksiyonel bileşen mi? Gıdalarda fonksiyonellik. Gıda 39(1): 57-62
Mortazavian, A.M., Mohammadi, R., Sohrabvandi, S., 2012. Delivery of Probiotic Microorganisms into Gastrointestinal Tract by Food Products. In: T. Brzozowski (Editor), New Advances in the Basic and Clinical Gastroenterology, InTech, 121-147. [5] Anonim, 2015a. http://www.statista.com/statistics/252941/probiotic- products-sales-worldwide-by-region/. Erişim tarihi: 20.04.2015 [6] Anonim, 2014a. http://www.marketsandmarkets.com/PressReleases /probiotics.asp. Erişim tarihi: 18.11.2014
Anonim., 2002. FAO/WHO. Guidelines for the evaluations of probiotics in food. Food and Agriculture Organization Working Group Report. 01.05.2002: 1-11.
Ghadimi, D., lster-Holst, R.F., de Vrese, M., Winkler, P., Heller, K.J., Schrezenmeir, J., 2008. Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobiology 213: 677-692.
Nabavi, S., Rafraf, M., Somi, M.H., Homayouni- Rad, A., Jafarabadi, M., A., 2014. Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease. Journal of Dairy Science 97: 1-8.
West, N.P., Horn, P.L., Barrett, S., Warren, H.S., Lehtinen, M.J., Koerbin, G., Brun, M., Pyne, D.B., Lahtinen, S.J., Fricker, P.A., Cripps, A.W., 2014a. Supplementation with a single and double strain probiotic on the innate immune system for respiratory illness. European Society for Clinical Nutrition and Metabolism 9: 178-184.
West, N.P., Horn, P.L., Pyne, D.B., Gebski, V.J., Lahtinen, S.J., Fricker, P.A., Cripps, A.W., 2014b. Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals. Clinical Nutrition 33: 581-587.
Narayanan, R., 2013. Current legistations on probiotic products. Journal of Agriculture Sciences 1(2): 18-24.
Arora, M., Sharma, S., Baldi, A., 2013. Comparative Insight of regulatory guidelines for probiotics in USA, India and Malaysia: A critical review. International Journal of Biotechnology for Wellness Industries 2: 51-64.
Anonim, 2006a. FAO/WHO. Probiotics in food. Health and nutritional properties and guidelines for evaluation. FAO Food Nutrition Paper 85 56p.
Anonim, 2006b. EC, Corrigendum to regulation (EC) No. 1924/2006 of the European parliament and of the council of 20 December 2006 on nutritional and health claims made on foods. Official Journal of the European Union. 18.01.2007: 1-16.
Van Loveren, H., Sanz, Y., Salminen, S., 2012. Health claims in Europe: Probiotics and prebiotics as case examples. Annual Review Food Science Technology 3: 247-261.
Patel, A., Smith, C., Knowles, T., Lin, Y.L., 2012. Nutrition and health claims: An enforcement perspective. Trends in Food Science & Technology 28: 15-22.
Gilsenan, M.,B., 2011. Nutrition & health claims in the European Union: A regulatory overview. Trends in Food Science & Technology 22: 536-542.
Anonim, 2012. EFSA. Scientific opinion on the substantiation of health claims related to Lactobacillus casei DG CNCM I-1572 and decreasing potentially pathogenic gastro intestinal microorganisms assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006;10 (6): 2723-2738. further
Hoffmann, D.E., Fraser, C.M., Palumbo, F., Ravel, J., Rowthorn, V., Schwartz, J., 2013. Federal Regulation of Probiotics: An Analysis of the Existing Regulatory Framework and Recommendations for alternative Frameworks. Final Report, University of Maryland Francis King Carey School of Law, Baltimore, Maryland, Amerika Birleşik Devleti, 116p.
Anonim., 2014b. What's new (&old ) in regulation of EU content/uploads/2013/07/Elinor_IPC_June_2013.pd f. Erişim tarihi: 23.11.2014.
Anonim., 2014c. EFSA. Discussion paper on the revision of the guidance on the scientific requirements for health claims related to gut and immune function. Technical Report 6p.
Venugopalan, V., Shriner, K. A., Beringer, A.W., 2010. Regulatory oversight and safety of probiotic use. Emerging Infectious Diseases 16(11): 1661- 1665.
Degnan F.H., 2012. Clinical studies involving probiotics when FDA's investigational new drug rubric applies and when it may not. Gut Microbes 3(6): 485-489.
Shimizu, M., 2012. Functional food in Japan: Current status and future of gut-modulating food. Journal of Food and Drug Analysis 20(1): 213-216.
Anonim., 2013. Functional food concepts and products http://www.vitafoods.eu.com/files/annav2.pptx.pdf Erişim tarihi: 21.11.2014. in Japan. [27] Anonim, 2015b. http://www.mhlw.go.jp/english/topics/foodsafety/fhc/ 02.html Erişim tarihi: 21.02.2015.
Anonim, 2015c. Guidelines and Criteria for Evaluation of Efficacy, Safety and Health Claim of Probiotic http://poshan.nic.in:80/jspui/handle/DL/1161. Erişim Tarihi: 25.02.2015. Products in India.
Anonim, 2011. Türk Gıda Kodeksi-Etiketleme Yönetmeliği. T.C. Resmi Gazete 29.12.2011 tarih ve 28157 sayı. Başbakanlık Mevzuatı Geliştirme ve Yayın Genel Müdürlüğü, Ankara.